2025年4月5日 星期六
首页        期刊介绍        编委会        投稿指南        期刊订阅        广告合作        联系我们        English
河北医学  2023, Vol. 29 Issue (7): 1068-1073    DOI: 10.3969/j.issn.1006-6233.2023.07.03
  论著 本期目录 | 过刊浏览 | 高级检索 |
基于AMPK-ACC信号通路探究miR-543对肺癌细胞放疗敏感性的机制研究
储祥健, 曹海燕, 戴美云
江苏省如皋市人民医院, 江苏 如皋 226500
The Mechanism of miR-543 on Radiosensitivity in Lung Cancer Cells Based on AMPK-ACC Signaling Pathway
CHU Xiangjian, CAO Haiyan, DAI Meiyun
Rugao People's Hospital, Jiangsu Rugao 226500, China
全文: PDF (2936 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的: 放射抗性是非小细胞肺癌(Non-small cell lung carcinoma ,NSCLC)放疗的一个重要障碍。据报道,miR-543在包括NSCLC在内的各种类型的癌症中是一种肿瘤促进因子。本研究旨在探索miR-543在调节NSCLC细胞放射敏感性中的潜在作用。方法: qRT-PCR检测miR-543的表达;CCK8、集落形成实验和流式细胞术等手段探究miR-543对NSCLC细胞生物学功能的影响。WB检测AMPK-ACC信号通路相关蛋白的表达。利用回复实验和辐射处理实验进一步验证miR-543通过AMPK-ACC信号通路对NSCLC细胞的恶性进展和放疗抗性的影响。结果: miR-53在NSCLC组织和细胞中均表达上调。沉默miR-53可以抑制NSCLC细胞的增殖能力,促进细胞周期阻滞和凋亡的发生,减弱放疗抗性。此外,miR-53参与调控AMPK-ACC信号通路,而使用compound C(AMPK-ACC信号通路的抑制剂)可以减弱miR-53沉默对NSCLC细胞行为及放疗敏感性的影响。结论: 本研究的结果表明,miR-53可以通过调控AMPK-ACC信号通路增强NSCLC细胞的放疗抗性的机制,提示靶向miR-53可能是改善NSCLC的放射治疗敏感性的潜在治疗靶点。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
储祥健
曹海燕
戴美云
关键词 miR-543非小细胞肺癌放疗抗性AMPK-ACC信号通路    
AbstractObjective: To explore the potential role of miR-543 in regulating the radiosensitivity of NSCLC cells. Methods: The expression of miR-543 was detected by qRT-PCR; CCK8,colony formation assay and flow cytometry were used to explore the effect of miR-543 on the biological function of NSCLC cells.The expression of proteins related to AMPK-ACC signaling pathway was detected by WB.Reversion experiments and radiation treatment experiments were used to further verify the effect of miR-543 on the malignant progression and radiotherapy resistance of NSCLC cells through the AMPK-ACC signaling pathway. Results: miR-53 was up-regulated in NSCLC tissues and cells.Silencing miR-53 can inhibit the proliferation ability of NSCLC cells,promote cell cycle arrest and apoptosis,and weaken radiotherapy resistance.In addition,miR-53 is involved in the regulation of AMPK-ACC signaling pathway,and the use of compound C (an inhibitor of AMPK-ACC signaling pathway) can attenuate the effect of miR-53 silencing on NSCLC cell behavior and radiosensitivity. Conclusion: The results of this study suggest that miR-53 can enhance the radiotherapy resistance mechanism in NSCLC cells by regulating the AMPK-ACC signaling pathway,suggesting that targeting miR-53 may be a potential therapeutic target to improve the radiotherapy sensitivity in NSCLC.
Key wordsmiR-543    Non-small cell lung carcinoma    Radiotherapy resistance    AMPK-ACC pathway
    
基金资助:江苏省优势学科建设工程项目,(编号:YSHL0814-789)
通讯作者: 曹海燕   
引用本文:   
储祥健, 曹海燕, 戴美云. 基于AMPK-ACC信号通路探究miR-543对肺癌细胞放疗敏感性的机制研究[J]. 河北医学, 2023, 29(7): 1068-1073.
CHU Xiangjian, CAO Haiyan, DAI Meiyun. The Mechanism of miR-543 on Radiosensitivity in Lung Cancer Cells Based on AMPK-ACC Signaling Pathway. HeBei Med, 2023, 29(7): 1068-1073.
链接本文:  
http://www.hbyxzzs.cn/CN/10.3969/j.issn.1006-6233.2023.07.03     或     http://www.hbyxzzs.cn/CN/Y2023/V29/I7/1068
冀ICP备2025106803号    冀公网安备13080202000786号
版权所有 © 2016 《河北医学》杂志社
本系统由北京玛格泰克科技发展有限公司设计开发